artesunate (LJPC-0118) / Innoviva - LARVOL DELTA

Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer (Multidisciplinary Digital Publishing Institute) - "Artesunate and navitoclax both demonstrated antiproliferative effects on 2D and 3D ovarian cancer cell models as single agents. Upon combination of navitoclax with artesunate, antineoplastic drug synergy was also observed in each of the 2D cell lines and ovarian tumor organoid models tested."

Preclinical • Ovarian Cancer